BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 11738742)

  • 21. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.
    Wang QC; Feng ZH; Zhou YX; Nie QH
    World J Gastroenterol; 2005 Jan; 11(4):557-60. PubMed ID: 15641145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination.
    Vidalin O; Tanaka E; Spengler U; Trépo C; Inchauspé G
    DNA Cell Biol; 1999 Aug; 18(8):611-21. PubMed ID: 10463057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein-expressing DNA vaccine: role of dendritic cells.
    Ou-Yang P; Hwang LH; Tao MH; Chiang BL; Chen DS
    J Med Virol; 2002 Mar; 66(3):320-8. PubMed ID: 11793383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
    Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein.
    Moriya O; Matsui M; Osorio M; Miyazawa H; Rice CM; Feinstone SM; Leppla SH; Keith JM; Akatsuka T
    Vaccine; 2001 Dec; 20(5-6):789-96. PubMed ID: 11738742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: a preventative vaccine strategy.
    Torresi J; Bharadwaj M; Jackson DC; Gowans EJ
    Curr Drug Targets; 2004 Jan; 5(1):41-56. PubMed ID: 14738217
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.